FAST BioMedical Successfully Completes Open-Label Proof-of-Concept Study for Measuring Interstitial Volume
Conducted at the Richard L. Roudebush VA Medical Center in Indianapolis, the study evaluated the safety, tolerability and performance of the FAST Technology in chronic dialysis patients with extremely reduced or no kidney function.